Jenny Reardon
Showing 1–1 of 1 transcripts.
- Goldman Sachs24 min
Jenny Reardon: The Science and Ethics of Genomics
Dr. Jenny Reardon, a scholar who transitioned from molecular biology to Science and Technology Studies, outlines the evolution from the cost-prohibitive Human Genome Project to the current era where petabytes of data necessitate population-centric analysis rather than individual interpretation. She highlights that despite achieving the "1,000-dollar genome" milestone, the field now grapples with interpreting vast numbers of variants of unknown significance, facing ethical risks from loopholes in the Genetic Non-Discrimination Act that leave consumers vulnerable to insurance discrimination. Furthermore, Reardon challenges the narrative of precision medicine by emphasizing the biological messiness of gene editing tools like CRISPR and warning against the misuse of personal genomic data for law enforcement and pharmaceutical trials without adequate safeguards.